595 filings
8-K
CTIC
CTI BioPharma Corp
26 Jun 23
Termination of a Material Definitive Agreement
8:51am
8-K
CTIC
CTI BioPharma Corp
30 May 23
CTI BioPharma Announces Cancellation of its 2023 Annual Meeting of Stockholders
5:20pm
8-K
CTIC
CTI BioPharma Corp
10 May 23
Tender and Support Agreement
8:05am
8-K
CTIC
CTI BioPharma Corp
6 Mar 23
CTI BioPharma Reports Fourth Quarter and Full Year 2022 Financial Results
4:02pm
8-K
CTIC
CTI BioPharma Corp
7 Nov 22
CTI BioPharma Reports Third Quarter 2022 Financial Results
4:07pm
8-K
y1qs85l kdx
13 Oct 22
Departure of Directors or Certain Officers
5:31pm
8-K
7l40d2kvu98l d1s
28 Sep 22
Other Events
4:05pm
8-K
ghxt7ah4c17g85ugtf
15 Aug 22
Other Events
9:04am
8-K
d28x4
8 Aug 22
CTI BioPharma Reports Second Quarter 2022 Financial Results
4:08pm
8-K
gym6549novp6uf550a
3 Jun 22
Departure of Directors or Certain Officers
4:06pm
8-K
22h6is7uqv5
12 May 22
CTI BioPharma Reports First Quarter 2022 Financial Results
4:07pm
8-K
uwb9h0ueci wnbvz
31 Mar 22
CTI BioPharma Reports Fourth Quarter and Full Year 2021 Financial Results
4:04pm
8-K
qju2hiyk j67b
4 Mar 22
Departure of Directors or Certain Officers
5:04pm
8-K
ayxv s6z2fuy52ktr7
1 Mar 22
CTI BioPharma Announces FDA Accelerated Approval of VONJOâ„¢ (pacritinib) for the Treatment of Adult Patients with Myelofibrosis and Thrombocytopenia
8:02pm
8-K
35pcdp281k3 h1
25 Aug 21
Entry into a Material Definitive Agreement
8:06am
8-K
sn2w0e rxl
24 Aug 21
CTI BioPharma Announces Appointment of Diane Parks to Its Board of Directors
9:42pm
8-K
c9e0er640d
5 Aug 21
CTI BioPharma Reports Second Quarter 2021 Financial Results
4:10pm
8-K
xqbye7rf
7 Jun 21
Departure of Directors or Certain Officers
5:28pm
8-K
qg84wnk1c
1 Jun 21
CTI BioPharma Reports First Quarter 2021 Financial Results
4:09pm
8-K
cs9e 4n7lpnt1x7
6 Apr 21
Entry into a Material Definitive Agreement
4:02pm